ArticleClinical rheumatology2020

Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study.

Aran Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.